{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T05:55:16Z","timestamp":1772690116732,"version":"3.50.1"},"reference-count":27,"publisher":"Impact Journals, LLC","issue":"47","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,11,22]]},"DOI":"10.18632\/oncotarget.12844","type":"journal-article","created":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T14:22:51Z","timestamp":1477318971000},"page":"77916-77925","source":"Crossref","is-referenced-by-count":17,"title":["<i>Pseudomonas aeruginosa<\/i>-mannose-sensitive hemagglutinin inhibits pancreatic cancer cell proliferation and induces apoptosis via the EGFR pathway and caspase signaling"],"prefix":"10.18632","volume":"7","author":[{"given":"Xi","family":"Cheng","sequence":"first","affiliation":[{"name":"Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China"},{"name":"Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingrui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijian","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China"},{"name":"Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China"},{"name":"Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiping","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China"},{"name":"Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China"},{"name":"Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqian","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China"},{"name":"Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baiyong","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China"},{"name":"Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenghong","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China"},{"name":"Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihua","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China"},{"name":"Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,10,24]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1056\/NEJMra091557","article-title":"Pancreatic cancer","volume":"362","author":"Hidalgo","year":"2010","journal-title":"N Eng J Med"},{"key":"2","doi-asserted-by":"publisher","first-page":"11151","DOI":"10.18632\/oncotarget.7098","article-title":"A systematic review of serum autoantibodies as biomarkers for pancreatic cancer detection","volume":"7","author":"Brenner","year":"2016","journal-title":"Oncotarget"},{"key":"3","doi-asserted-by":"publisher","first-page":"67314","DOI":"10.18632\/oncotarget.12007","article-title":"Early tumor shrinkage as a predictor of favorable outcomes in patients with advanced pancreatic cancer treated with FOLFIRINOX","volume":"7","author":"Sasaki","year":"2016","journal-title":"Oncotarget"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Stathis, Moore. Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev Clin Oncol. 2010 Mar 7; pp. 163\u201372. https:\/\/doi.org\/10.1038\/nrclinonc.2009.236.","DOI":"10.1038\/nrclinonc.2009.236"},{"key":"5","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa032295","article-title":"A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer [J]","volume":"350","author":"Friess","year":"2004","journal-title":"N Eng J Med"},{"key":"6","doi-asserted-by":"publisher","first-page":"17103","DOI":"10.18632\/oncotarget.7931","article-title":"Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine","volume":"7","author":"Pellecchia","year":"2016","journal-title":"Oncotarget"},{"key":"7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/jso.24147","article-title":"S-1 plus nab-paclitaxel is a promising regimen for pancreatic cancer in a preclinical model","volume":"113","author":"Kodera","year":"2016","journal-title":"J Surg Oncol"},{"key":"8","doi-asserted-by":"publisher","first-page":"46988","DOI":"10.18632\/oncotarget.9029","article-title":"Augmentation of response to nab-paclitaxel by inhibition of insulin-like growth factor (IGF) signaling in preclinical pancreatic cancer models","volume":"7","author":"Schwarz","year":"2016","journal-title":"Oncotarget"},{"key":"9","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1186\/s12885-016-2671-9","article-title":"NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice","volume":"16","author":"Orditura","year":"2016","journal-title":"BMC Cancer"},{"key":"10","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1111\/liv.12644","article-title":"Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR\/Akt\/I\u03baB\u03b2\/NF-\u03baB pathway","volume":"35","author":"Hu","year":"2015","journal-title":"Liver Int"},{"key":"11","doi-asserted-by":"publisher","first-page":"49384","DOI":"10.18632\/oncotarget.9891","article-title":"PA-MSHA in combination with EGFR tyrosine kinase inhibitor: A new strategy to overcome the drug resistance of non-small cell lung cancer cells","volume":"7","author":"Fu","year":"2016","journal-title":"Oncotarget"},{"key":"12","doi-asserted-by":"publisher","first-page":"6913","DOI":"10.1007\/s13277-015-4451-6","article-title":"The MSHA strain of Pseudomonas aeruginosa (PA-MSHA) inhibits gastric carcinoma progression by inducing M1 macrophage polarization","volume":"37","author":"Cai","year":"2016","journal-title":"Tumour Biol"},{"key":"13","doi-asserted-by":"publisher","first-page":"66491","DOI":"10.18632\/oncotarget.11582","article-title":"Metabolic flux-driven sialylation alters internalization, recycling, and drug sensitivity of the epidermal growth factor receptor (EGFR) in SW1990 pancreatic cancer cells","volume":"7","author":"Yarema","year":"2016","journal-title":"Oncotarget"},{"key":"14","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1158\/0008-5472.CAN-15-1488","article-title":"Neuropilin-2 Regulates Endosome Maturation and EGFR Trafficking to Support Cancer Cell Pathobiology","volume":"76","author":"Datta","year":"2016","journal-title":"Cancer Res"},{"key":"15","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3892\/or.2016.4865","article-title":"Leukemia inhibitory factor receptor negatively regulates the metastasis of pancreatic cancer cells in vitro and in vivo","volume":"36","author":"Qiu","year":"2016","journal-title":"Oncol Rep"},{"key":"16","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1136\/gutjnl-2015-309193","article-title":"Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy","volume":"65","author":"Marchesi","year":"2016","journal-title":"Gut"},{"key":"17","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0140-6736(16)30583-9","article-title":"JASPAC 01 Study Group. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)","volume":"388","author":"Ohashi","year":"2016","journal-title":"Lancet"},{"key":"18","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1007\/s12094-015-1471-z","article-title":"Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse","volume":"18","author":"Barone","year":"2016","journal-title":"Clin Transl Oncol"},{"key":"19","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/bjc.2016.222","article-title":"FOLFIRINOX for advanced pancreatic cancer: the Princess Margaret Cancer Centre experience","volume":"115","author":"Knox","year":"2016","journal-title":"Br J Cancer"},{"key":"20","doi-asserted-by":"publisher","first-page":"6987","DOI":"10.3748\/wjg.v22.i31.6987","article-title":"FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer","volume":"22","author":"Giovannetti","year":"2016","journal-title":"World J Gastroenterol"},{"key":"21","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1002\/ijc.30280","article-title":"Systematic review and meta-analysis of the risk of severe and life-threatening thromboembolism in cancer patients receiving anti-EGFR monoclonal antibodies (cetuximab or panitumumab)","volume":"139","author":"Stewart","year":"2016","journal-title":"Int J Cancer"},{"key":"22","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/MPA.0000000000000460","article-title":"Pancreatic Tumor Progression Associated With CD133 Overexpression: Involvement of Increased TERT Expression and Epidermal Growth Factor Receptor-Dependent Akt Activation","volume":"45","author":"Cheng","year":"2016","journal-title":"Pancreas"},{"key":"23","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/path.4666","article-title":"Inactivation of TGF\u03b2 receptor II signalling in pancreatic epithelial cells promotes acinar cell proliferation, acinar-to-ductal metaplasia and fibrosis during pancreatitis","volume":"238","author":"Graf","year":"2016","journal-title":"J Pathol"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Li, Shen, Cheng, Ma, Jing, Liu, Yang, Peng, Qiu. Phenotypic and Signaling Consequences of a Novel Aberrantly Spliced Transcript FGF Receptor-3 in Hepatocellular Carcinoma. Cancer Res. 2016 Jun 7. [Epub ahead of print].","DOI":"10.1158\/0008-5472.CAN-15-3385"},{"key":"25","doi-asserted-by":"publisher","first-page":"37215","DOI":"10.18632\/oncotarget.9295","article-title":"GADD45\u03b2 induction by S-adenosylmethionine inhibits hepatocellular carcinoma cell proliferation during acute ischemia-hypoxia","volume":"7","author":"Qiu","year":"2016","journal-title":"Oncotarget"},{"key":"26","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.3892\/ijo.2012.1415","article-title":"Emerging role of autophagy during ischemia-hypoxia and reperfusion in hepatocellular carcinoma","volume":"40","author":"Qiu","year":"2012","journal-title":"Int J Oncol"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Zhang, Wang, Qin, Cong, Shao, Du, Ni, Li, Ding. A novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin-3 associated signaling pathways. Oncogene. 2016 Sep 12. [Epub ahead of print]https:\/\/doi.org\/10.1038\/onc.2016.306.","DOI":"10.1038\/onc.2016.306"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12844","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T13:04:19Z","timestamp":1596719059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,24]]},"references-count":27,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2016,11,22]]}},"alternative-id":["12844","27788491"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.12844","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,24]]}}}